Back to top

Leerink Partners Keeps Their Buy Rating on Century Therapeutics (IPSC)

In a report released on May 19, Daina Graybosch from Leerink Partners maintained a Buy rating on Century Therapeutics (IPSC – Research Report), wit...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Century Therapeutics, Inc. (IPSC)